Loading...
Five siRNAs targeting three SNPs in Huntingtin may provide therapy for three-quarters of Huntington’s disease patients
Among dominant neurodegenerative disorders, Huntington’s disease (HD) is perhaps the best candidate for treatment with small interfering RNAs (siRNAs) [1–9]. Invariably fatal, HD is caused by expansion of a CAG repeat in the Huntingtin gene, creating an extended polyglutamine tract that makes the Hu...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
2009
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2746439/ https://ncbi.nlm.nih.gov/pubmed/19361997 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.cub.2009.03.030 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|